Loading data
TARSNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 451.36 m USD | 182.95 m USD | 17.45 m USD | 25.82 m USD | 57.03 m USD |
| Research and development expense | 64.32 m USD | 53.39 m USD | 50.31 m USD | 42.62 m USD | 41.71 m USD |
| Selling, general and administrative expense | 427.32 m USD | 237.31 m USD | 108.7 m USD | 44.95 m USD | — |
| Operating profit | -70.97 m USD | -120.57 m USD | -143.16 m USD | -62.71 m USD | -12.16 m USD |
| Interest expense | — | — | 3.35 m USD | 2.2 m USD | 0 USD |
| Profit before tax | -64.36 m USD | -115.55 m USD | -135.89 m USD | -62.1 m USD | -13.77 m USD |
| Income tax expense | 2.06 m USD | 0 USD | 0 USD | -4 k USD | 55 k USD |
| Net income (reported basis) | -66 m USD | -116 m USD | -136 m USD | -62.09 m USD | -13.83 m USD |
| Basic earnings per share | -1.59 USD/share | -3.07 USD/share | -4.62 USD/share | -2.52 USD/share | -0.67 USD/share |
| Diluted earnings per share | -1.59 USD/share | -3.07 USD/share | -4.62 USD/share | -2.52 USD/share | -0.67 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.